BALLARINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 12.212
AS - Asia 8.587
EU - Europa 6.826
SA - Sud America 1.062
AF - Africa 192
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 13
Totale 28.943
Nazione #
US - Stati Uniti d'America 11.508
SG - Singapore 2.759
IT - Italia 2.024
CN - Cina 1.789
VN - Vietnam 1.746
DE - Germania 1.229
RU - Federazione Russa 863
HK - Hong Kong 833
BR - Brasile 803
SE - Svezia 596
CA - Canada 581
IE - Irlanda 401
GB - Regno Unito 391
FR - Francia 257
IN - India 247
UA - Ucraina 219
KR - Corea 215
BD - Bangladesh 189
FI - Finlandia 168
AT - Austria 136
ID - Indonesia 127
JP - Giappone 116
TR - Turchia 105
AR - Argentina 99
IQ - Iraq 85
NL - Olanda 79
DK - Danimarca 78
PL - Polonia 73
MX - Messico 71
CH - Svizzera 67
LT - Lituania 67
ES - Italia 64
ZA - Sudafrica 60
PK - Pakistan 53
AU - Australia 46
BE - Belgio 45
SA - Arabia Saudita 42
EC - Ecuador 37
PH - Filippine 34
CO - Colombia 33
EG - Egitto 30
IR - Iran 30
UZ - Uzbekistan 29
VE - Venezuela 29
MY - Malesia 25
MA - Marocco 23
PY - Paraguay 22
CL - Cile 20
TW - Taiwan 18
AE - Emirati Arabi Uniti 16
TN - Tunisia 16
IL - Israele 15
KZ - Kazakistan 15
TH - Thailandia 14
RO - Romania 13
CR - Costa Rica 12
ET - Etiopia 12
JO - Giordania 12
BG - Bulgaria 10
EU - Europa 10
HN - Honduras 10
KE - Kenya 10
OM - Oman 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
HU - Ungheria 9
JM - Giamaica 9
UY - Uruguay 9
AO - Angola 8
NG - Nigeria 8
KW - Kuwait 7
NP - Nepal 7
LB - Libano 6
PE - Perù 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
KG - Kirghizistan 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
BH - Bahrain 4
BO - Bolivia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
LA - Repubblica Popolare Democratica del Laos 3
MN - Mongolia 3
MT - Malta 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BN - Brunei Darussalam 2
CU - Cuba 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
MM - Myanmar 2
MU - Mauritius 2
Totale 28.907
Città #
Ann Arbor 1.946
Singapore 1.664
Dallas 1.130
Ashburn 1.021
San Jose 967
Frankfurt am Main 821
Hong Kong 790
Milan 772
Ho Chi Minh City 525
Hanoi 402
Toronto 390
Dublin 388
Chandler 379
Wilmington 336
New York 313
Los Angeles 304
Beijing 281
Dearborn 259
Woodbridge 248
Boardman 233
Houston 206
Fairfield 192
Jacksonville 191
Santa Clara 189
Chicago 179
Council Bluffs 176
Hefei 168
Seoul 158
Princeton 149
The Dalles 132
Rome 123
Vienna 114
Shanghai 106
Buffalo 100
Nanjing 100
Seattle 98
Moscow 91
São Paulo 90
Lauterbourg 89
Jakarta 84
Munich 84
Guangzhou 81
Helsinki 75
Orem 74
Columbus 65
Da Nang 56
Tokyo 56
Haiphong 53
Dong Ket 51
London 51
Montreal 50
Zurich 49
Vilnius 48
Warsaw 48
Denver 44
Brooklyn 39
Baghdad 38
Cambridge 38
Carate Brianza 38
Chennai 38
Rio de Janeiro 38
Saint Petersburg 38
Atlanta 37
Turku 37
Altamura 36
Hải Dương 34
Lawrence 34
Nuremberg 34
Phoenix 34
Shenyang 34
Florence 32
Johannesburg 31
Pune 31
Basingstoke 30
Biên Hòa 30
Lachine 30
Stockholm 30
Brussels 29
Ha Long 29
Jinan 28
Kent 28
Ninh Bình 28
Ottawa 28
Tashkent 28
Washington 28
Daejeon 27
Nanchang 27
Poplar 27
Changsha 26
Falls Church 26
Fremont 26
Sacramento 26
Andover 25
Can Tho 25
Mexico City 25
Quận Bình Thạnh 25
Manchester 24
Amsterdam 23
Bắc Ninh 23
Dhaka 23
Totale 18.154
Nome #
CIPN and its mechanism of development 634
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 610
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 584
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 560
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 511
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 504
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 491
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 478
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 472
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 466
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 452
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 438
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 436
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 432
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 428
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 425
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 414
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 412
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 402
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 371
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 342
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 342
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 341
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 331
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 327
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 325
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 324
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 316
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 314
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 313
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 311
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 308
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 307
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 307
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 302
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 294
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 292
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 289
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 283
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 281
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 280
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 279
Histone deacetylases inhibitors: a new frontier for neuroprotection? 278
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 277
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 276
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 274
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 272
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 271
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 267
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 266
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 266
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 265
MSCs effect on Dark Agouti rats affected by chronic EAE 262
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 261
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 260
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 260
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 259
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 258
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 258
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 256
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 250
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 250
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 246
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment 244
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 242
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 237
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 236
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 235
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 232
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 232
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation 227
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 226
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 225
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 224
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 221
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 221
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 218
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 217
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 216
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 214
Nose-to-brain delivery of polymeric nanoparticles 213
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 210
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 208
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 202
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 201
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 194
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 192
Refinement Of Dorsal Root Ganglia Neurons Morphometry 184
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 170
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 169
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 164
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 156
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED ALTERATIONS LEADING TO PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 155
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 155
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 154
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 149
Blood NfL as a potential axonal damage marker in different CIPN rat models. 135
Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity 120
THYMOQUINONE AS A POSSIBLE NEUROPROTECTIVE AGENT AGAINST PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 118
Paclitaxel Alters Drg SGCs in Animals with Peripheral Neuropathy 115
Totale 29.091
Categoria #
all - tutte 87.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.231 217 516 292 231 198 314 57 103 133 40 62 68
2023/20241.699 57 64 57 116 197 352 302 98 101 47 57 251
2024/20254.784 258 459 436 224 384 208 323 199 548 665 430 650
2025/202613.663 1.871 1.100 1.607 1.192 1.123 723 1.795 603 1.038 1.048 752 811
2026/2027370 370 0 0 0 0 0 0 0 0 0 0 0
Totale 29.904